Rania M Hathout
Overview
Explore the profile of Rania M Hathout including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
949
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Safwat S, Ishak R, Hathout R, Mortada N
Ther Deliv
. 2024 Nov;
16(1):43-61.
PMID: 39589423
Aims: Breast cancer is the second leading cause of death worldwide. Conventional chemotherapeutic therapies lack the specific targeting effect toward the cancerous cells resulting in extensive side effects. Our current...
2.
El-Maraghy C, Medhat P, Hathout R, Ayad M, Fares N
BMC Chem
. 2024 Jul;
18(1):131.
PMID: 39010206
A fast eco-friendly colorimetric method was developed for the determination of Tobramycin in drug substance, ophthalmic formulations, and spiked human plasma using silver nanoparticles optical sensor. Even though tobramycin is...
3.
Ali D, Gad H, Hathout R
Gels
. 2024 Jun;
10(6).
PMID: 38920901
The current research investigated the use of gelatin nanoparticles (GNPs) for enhancing the cytotoxic effects of nivolumab, an immune checkpoint inhibitor. The unique feature of GNPs is their biocompatibility and...
4.
Emam M, Elezaby R, Swidan S, Hathout R
Expert Rev Respir Med
. 2024 May;
18(3-4):127-143.
PMID: 38753449
Introduction: Wearing protective face masks and respirators has been a necessity to reduce the transmission rate of respiratory viruses since the outbreak of the coronavirus (COVID-19) disease. Nevertheless, the outbreak...
5.
Nasser N, Hathout R, Abd-Allah H, Sammour O
AAPS PharmSciTech
. 2024 Mar;
25(3):56.
PMID: 38448576
Novel p-coumaric acid microemulsion systems were developed to circumvent its absorption and bioavailability challenges. Simplex-lattice mixture design and machine learning methods were employed for optimization. Two optimized formulations were characterized...
6.
Hathout R, Ishak R, Shakshak D
Expert Opin Drug Deliv
. 2024 Feb;
21(2):325-335.
PMID: 38340063
Introduction: Transdermal delivery has been extensively investigated as a successful alternative to the oral and parenteral routes of administration. The use of polymeric nanoparticles as drug delivery systems through this...
7.
Gad S, El-Gogary R, George M, Hathout R
Int J Pharm
. 2023 Sep;
645:123387.
PMID: 37678474
Alzheimer's disease (AD) is a neurodegenerative disorder and the most relevant form of dementia affecting people worldwide. AD was reported to be associated with increased oxidative stress ending up with...
8.
El Zaafarany G, Hathout R, Ibrahim S
Int J Pharm
. 2023 Jul;
642:123204.
PMID: 37406947
This study presents a meta-analysis that compiles information collected from several studies aiming to prove, by evidence, that nanocarriers out-perform conventional formulations in augmenting the bioavailability of ocular topically administered...
9.
Emam M, Elezaby R, Swidan S, Loutfy S, Hathout R
Pharmaceutics
. 2023 May;
15(5).
PMID: 37242737
Background: Using face masks is one of the protective measures to reduce the transmission rate of coronavirus. Its massive spread necessitates developing safe and effective antiviral masks (filters) applying nanotechnology....
10.
Metwally A, Nayel A, Hathout R
Front Mol Biosci
. 2023 Jan;
9:1042720.
PMID: 36619167
prediction of the efficacy of siRNA ionizable-lipid nanoparticles is desirable as it can save time and resources dedicated to wet-lab experimentation. This study aims to computationally predict siRNA nanoparticles efficacy....